1. Nielsen SV, Kolmos HJ. Bacteraemia due to different groups of beta-haemolytic streptococci: a two-year survey and presentation of a case of recurring infection due to
eStreptococcus “quisimilis”. Infection. 1993; 21:358–361. PMID:
8132363.
2. Liao CH, Liu LC, Huang YT, Teng LJ, Hsueh PR. Bacteremia caused by group G Streptococci, Taiwan. Emerg Infect Dis. 2008; 14:837–840. PMID:
18439377.
3. Suzuki K, Nakamura A, Ishikura K, Imai H. Recurrent SDSE bacteraemia resulting in streptococcal toxic shock syndrome in a patient with Noonan syndrome. BMJ Case Rep. 2016; 2016:pii: bcr2016216092.
4. Trell K, Sendi P, Rasmussen M. Recurrent bacteremia with
Streptococcus dysgalactiae: a case-control study. Diagn Microbiol Infect Dis. 2016; 85:121–124. PMID:
26906192.
5. Takahashi T, Sunaoshi K, Sunakawa K, Fujishima S, Watanabe H, Ubukata K, et al. Clinical aspects of invasive infections with
Streptococcus dysgalactiae ssp.
equisimilis in Japan: differences with respect to
Streptococcus pyogenes and
Streptococcus agalactiae infections. Clin Microbiol Infect. 2010; 16:1097–1103. PMID:
19732082.
6. Fujita T, Horiuchi A, Ogawa M, Yoshida H, Hirose Y, Nagano N, et al. Genetic diversity in
Streptococcus dysgalactiae subsp.
equisimilis isolates from patients with invasive and noninvasive infections in a Japanese university hospital (2014-2015). Jpn J Infect Dis. 2017; 70:100–104. PMID:
27000456.
7. Takahashi T, Fujita T, Shibayama A, Tsuyuki Y, Yoshida H. Prevalence of complement-mediated cell lysis-like gene (
sicG) in
Streptococcus dysgalactiae subsp.
equisimilis isolates from Japan (2014–2016). Ann Lab Med. 2017; 37:297–304. PMID:
28445008.
8. Kim S, Byun JH, Park H, Lee J, Lee HS, Yoshida H, et al. Molecular epidemiological features and antibiotic susceptibility patterns of
Streptococcus dysgalactiae subsp.
equisimilis isolates from Korea and Japan. Ann Lab Med. 2018; 38:212–219. PMID:
29401555.
9. Ciszewski M, Szewczyk EM. Potential factors enabling human body colonization by animal
Streptococcus dysgalactiae subsp.
equisimilis strains. Curr Microbiol. 2017; 74:650–654. PMID:
28314902.
10. Kawabata S, Kuwata H, Nakagawa I, Morimatsu S, Sano K, Hamada S. Capsular hyaluronic acid of Group A Streptococci hampers their invasion into human pharyngeal epithelial cells. Microb Pathog. 1999; 27:71–80. PMID:
10458918.
11. CLSI. Performance standards for antimicrobial susceptibility testing: 22nd informational supplement. M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute;2012.
12. Lo HH, Cheng WS. Distribution of virulence factors and association with
emm polymorphism or isolation site among beta-hemolytic group G
Streptococcus dysgalactiae subspecies
equisimilis. APMIS. 2015; 123:45–52. PMID:
25244428.
13. Eriksson BK. Anal colonization of group G beta-hemolytic streptococci in relapsing erysipelas of the lower extremity. Clin Infect Dis. 1999; 29:1319–1320. PMID:
10524984.